substance p has been researched along with Cardiac Failure in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Arfsten, H; Bartko, PE; Cho, A; Goliasch, G; Haslacher, H; Hülsmann, M; Mascherbauer, J; Novak, J; Pavo, N; Prausmüller, S; Spinka, G; Strunk, G | 1 |
| Arrigo, M; Beauvais, F; Cohen-Solal, A; Launay, JM; Logeart, D; Nougué, H; Pezel, T; Picard, F; Sadoune, M; Vodovar, N | 1 |
| Dehlin, HM; Levick, SP | 1 |
| Fan, Z; Wang, H; Yang, C; Yang, J | 1 |
| Levick, SP; Meléndez, GC | 1 |
| Lang, NN; Mitchell, AJ; Newby, DE; Pawade, T; Shah, AS; Stirrat, CG; Venkatasubramanian, S | 1 |
| Cicha, MZ; Jones, SY; Kopp, UC | 1 |
| Janicki, JS; Law, BA; Levick, SP; Li, J; Meléndez, GC; Supowit, SC | 1 |
| Dawson, P; Fox, KA; Ludlam, CA; Newby, DE; Witherow, FN | 1 |
| Cicha, MZ; Kopp, UC; Smith, LA | 1 |
| Komarov, AM; Kramer, JH; Mak, IuT; Tejero-Taldo, MI; Weglicki, WB | 1 |
| Heywood, JT; Yun, D | 1 |
| Anand, IS; Clarke, D; Collins, P; Holdright, DR; Lindsay, DC; Poole-Wilson, PA | 1 |
| Paulus, WJ | 1 |
| Hirooka, Y; Imaizumi, T; Takeshita, A | 1 |
| Cooper, A; Heagerty, AM | 1 |
| Bergdahl, A; Edvinsson, L; Hedner, T; Nilsson, T; Sun, XY; Valdemarsson, S | 1 |
| Bronzwaer, JG; Heymes, C; Paulus, WJ; Shah, AM; Vanderheyden, M | 1 |
| Fox, KA; Helmy, A; Newby, DE; Webb, DJ; Witherow, FN | 1 |
| Frantz, S; Kelly, RA; Paulus, WJ | 1 |
| Davie, AP; McMurray, JJ | 1 |
| Harada, S; Hirooka, Y; Imaizumi, T; Masaki, H; Momohara, M; Tagawa, T; Takeshita, A | 1 |
| Edvinsson, L; Ekman, R; Hedner, P; Sjöholm, A; Valdemarsson, S | 1 |
| Berkenboom, G; Depierreux, M; Fontaine, J | 1 |
3 review(s) available for substance p and Cardiac Failure
| Article | Year |
|---|---|
Substance P in heart failure: the good and the bad.
Topics: Animals; Heart; Heart Failure; Humans; Sensory Receptor Cells; Substance P; Ventricular Remodeling | 2014 |
The nerve-heart connection in the pro-oxidant response to Mg-deficiency.
Topics: Animals; Antioxidants; Heart Failure; Humans; Inflammation; Magnesium Deficiency; Myocardium; Neurokinin-1 Receptor Antagonists; Neurons; Nitric Oxide; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Substance P | 2006 |
Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure.
Topics: Coronary Vessels; Diastole; Endothelium, Vascular; Heart Failure; Humans; Myocardial Contraction; Nitric Oxide; Substance P; Ventricular Function, Left | 1996 |
2 trial(s) available for substance p and Cardiac Failure
| Article | Year |
|---|---|
Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiography, Impedance; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Female; Forearm; Heart Failure; Heart Rate; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Plethysmography; Regional Blood Flow; Substance P; Urocortins; Vascular Resistance; Vasodilation | 2016 |
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Female; Forearm; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Plethysmography; Reference Values; Regional Blood Flow; Substance P; Vasodilation | 2001 |
19 other study(ies) available for substance p and Cardiac Failure
| Article | Year |
|---|---|
Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Enkephalins; Heart Failure; Humans; Neprilysin; Protein Precursors; Stroke Volume; Substance P | 2021 |
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Biphenyl Compounds; CD146 Antigen; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography; Female; Fructosamine; Glucagon-Like Peptide 1; Heart Failure; Humans; Interleukin-1 Receptor-Like 1 Protein; Male; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Substance P; Tetrazoles; Treatment Outcome; Troponin I; Valsartan | 2019 |
Relaxin: A novel therapy for acute heart failure.
Topics: Animals; Heart; Heart Failure; Humans; Substance P; Ventricular Remodeling | 2016 |
Targeting substance P and relaxin: A future combination therapy approach for heart failure?
Topics: Animals; Heart; Heart Failure; Humans; Substance P; Ventricular Remodeling | 2016 |
Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.
Topics: Afferent Pathways; Animals; Antihypertensive Agents; Dinoprostone; Disease Models, Animal; Endothelin A Receptor Antagonists; Heart Failure; Hydrostatic Pressure; Kidney; Kidney Pelvis; Male; Mechanoreceptors; Myocardium; Organ Size; Peptides, Cyclic; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium; Substance P; Ventricular Dysfunction, Left | 2010 |
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.
Topics: Animals; Apoptosis; Cell Degranulation; Collagen; Disease Models, Animal; Heart Failure; In Situ Nick-End Labeling; Male; Mast Cells; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Neurokinin A; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Time Factors; Tryptophan; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Remodeling | 2011 |
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Bradykinin; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide Fragments; Plethysmography; Substance P; Tissue Plasminogen Activator; Vasomotor System | 2002 |
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Heart Failure; Kidney; Losartan; Male; Models, Animal; Natriuresis; Neurons, Afferent; Pressure; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium; Sodium, Dietary; Substance P | 2003 |
Metastatic carcinoid disease presenting solely as high-output heart failure.
Topics: Carcinoid Heart Disease; Carcinoid Tumor; Diagnosis, Differential; Heart Failure; Humans; Male; Middle Aged; Substance P | 1994 |
Endothelial control of lower limb blood flow in chronic heart failure.
Topics: Acetylcholine; Female; Heart Failure; Humans; Leg; Male; Middle Aged; Muscle, Skeletal; Nitric Oxide; Papaverine; Regional Blood Flow; Substance P; Vascular Resistance; Vasodilator Agents | 1996 |
Role of endothelium in control of forearm blood flow in patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Arginine; Endothelium, Vascular; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vascular Resistance; Vasodilator Agents; Vasomotor System | 1996 |
Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adult; Arteries; Arteriosclerosis; Bradykinin; Cardiomyopathies; Coronary Circulation; Endothelium, Vascular; Female; Heart; Heart Failure; Heart Transplantation; Humans; Hypercholesterolemia; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Nitroprusside; Substance P; Vasodilation | 1998 |
Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Potassium; Rats; Rats, Sprague-Dawley; Substance P; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1999 |
Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.
Topics: Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Coronary Angiography; Female; Gene Expression Regulation, Enzymologic; Heart Failure; Humans; Male; Middle Aged; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Stroke Volume; Substance P; Ventricular Function, Left | 1999 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bradykinin; Confidence Intervals; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Failure; Humans; Male; Middle Aged; Substance P; Vasodilation | 2002 |
Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Endothelium, Vascular; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Regional Blood Flow; Substance P; Vascular Resistance; Vasodilation | 1992 |
Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Calcitonin Gene-Related Peptide; Catecholamines; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Renin; Substance P; Vasopressins | 1991 |
The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline.
Topics: Adolescent; Adult; Arteriosclerosis; Child; Child, Preschool; Coronary Vessels; Endothelium, Vascular; Female; Heart Failure; Humans; In Vitro Techniques; Infant; Isoproterenol; Male; Middle Aged; Norepinephrine; Potassium Chloride; Receptors, Adrenergic, beta; Substance P; Vasodilation | 1987 |